Cargando…
Faecal calprotectin and rectal histological inflammatory markers in cystic fibrosis: a single-centre study
OBJECTIVE: To analyse the association of faecal calprotectin with the genetic and clinical characteristics of paediatric patients with cystic fibrosis (PwCF). In a subset of these patients, we aimed to associate histological inflammatory features of rectal mucosa to faecal calprotectin levels. METHO...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058793/ https://www.ncbi.nlm.nih.gov/pubmed/36053631 http://dx.doi.org/10.1136/bmjpo-2022-001422 |
_version_ | 1784698189504315392 |
---|---|
author | Roda, Juliana Maia, Carla Almeida, Susana Oliveira, Rui Caetano Ferreira, Ricardo Oliveira, Guiomar |
author_facet | Roda, Juliana Maia, Carla Almeida, Susana Oliveira, Rui Caetano Ferreira, Ricardo Oliveira, Guiomar |
author_sort | Roda, Juliana |
collection | PubMed |
description | OBJECTIVE: To analyse the association of faecal calprotectin with the genetic and clinical characteristics of paediatric patients with cystic fibrosis (PwCF). In a subset of these patients, we aimed to associate histological inflammatory features of rectal mucosa to faecal calprotectin levels. METHODS: In a prospective study, faecal calprotectin levels were collected in all 23 PwCF attending our paediatric centre, together with demographic and clinical data. Associations between faecal calprotectin and clinical features were determined. In 11 of these patients, endoscopic rectal biopsies were obtained and the association between faecal calprotectin and histological inflammatory markers was analysed. Statistical analyses included Spearman’s correlation coefficient, Mann-Whitney U test and Fisher’s exact test. Sensitivity and specificity was calculated. RESULTS: Median age of PwCF was 12 years, 19 had pancreatic insufficiency (PI) (19/23). Seventeen (17/23) had elevated faecal calprotectin, and the median value was 88 µg/g (IQR=178 µg/g). Higher faecal calprotectin levels were observed in the PI group (101 vs 30 µg/g, p=0.027). No significant correlation between elevated faecal calprotectin level and body mass index z-score was found. Five patients (22%) reported abdominal pain, three (13%) complained of diarrhoea and three (13%) had constipation, but these symptoms were not associated with elevated faecal calprotectin. Unspecific focal rectal inflammation was found in four patients (4/11). An association between rectal mucosa inflammation and elevated faecal calprotectin was found (p=0.015). Sensitivity was 100% and specificity was 86%. CONCLUSIONS: In our PwCF, elevated faecal calprotectin was frequent, particularly if PI, and it was not related to gastrointestinal symptoms or malnutrition. Elevated faecal calprotectin was present in patients with histological evidence of rectal inflammation. Faecal calprotectin may be an indicator of asymptomatic rectal inflammation in PwCF. |
format | Online Article Text |
id | pubmed-9058793 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-90587932022-05-12 Faecal calprotectin and rectal histological inflammatory markers in cystic fibrosis: a single-centre study Roda, Juliana Maia, Carla Almeida, Susana Oliveira, Rui Caetano Ferreira, Ricardo Oliveira, Guiomar BMJ Paediatr Open Gastroenterology OBJECTIVE: To analyse the association of faecal calprotectin with the genetic and clinical characteristics of paediatric patients with cystic fibrosis (PwCF). In a subset of these patients, we aimed to associate histological inflammatory features of rectal mucosa to faecal calprotectin levels. METHODS: In a prospective study, faecal calprotectin levels were collected in all 23 PwCF attending our paediatric centre, together with demographic and clinical data. Associations between faecal calprotectin and clinical features were determined. In 11 of these patients, endoscopic rectal biopsies were obtained and the association between faecal calprotectin and histological inflammatory markers was analysed. Statistical analyses included Spearman’s correlation coefficient, Mann-Whitney U test and Fisher’s exact test. Sensitivity and specificity was calculated. RESULTS: Median age of PwCF was 12 years, 19 had pancreatic insufficiency (PI) (19/23). Seventeen (17/23) had elevated faecal calprotectin, and the median value was 88 µg/g (IQR=178 µg/g). Higher faecal calprotectin levels were observed in the PI group (101 vs 30 µg/g, p=0.027). No significant correlation between elevated faecal calprotectin level and body mass index z-score was found. Five patients (22%) reported abdominal pain, three (13%) complained of diarrhoea and three (13%) had constipation, but these symptoms were not associated with elevated faecal calprotectin. Unspecific focal rectal inflammation was found in four patients (4/11). An association between rectal mucosa inflammation and elevated faecal calprotectin was found (p=0.015). Sensitivity was 100% and specificity was 86%. CONCLUSIONS: In our PwCF, elevated faecal calprotectin was frequent, particularly if PI, and it was not related to gastrointestinal symptoms or malnutrition. Elevated faecal calprotectin was present in patients with histological evidence of rectal inflammation. Faecal calprotectin may be an indicator of asymptomatic rectal inflammation in PwCF. BMJ Publishing Group 2022-04-28 /pmc/articles/PMC9058793/ /pubmed/36053631 http://dx.doi.org/10.1136/bmjpo-2022-001422 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Gastroenterology Roda, Juliana Maia, Carla Almeida, Susana Oliveira, Rui Caetano Ferreira, Ricardo Oliveira, Guiomar Faecal calprotectin and rectal histological inflammatory markers in cystic fibrosis: a single-centre study |
title | Faecal calprotectin and rectal histological inflammatory markers in cystic fibrosis: a single-centre study |
title_full | Faecal calprotectin and rectal histological inflammatory markers in cystic fibrosis: a single-centre study |
title_fullStr | Faecal calprotectin and rectal histological inflammatory markers in cystic fibrosis: a single-centre study |
title_full_unstemmed | Faecal calprotectin and rectal histological inflammatory markers in cystic fibrosis: a single-centre study |
title_short | Faecal calprotectin and rectal histological inflammatory markers in cystic fibrosis: a single-centre study |
title_sort | faecal calprotectin and rectal histological inflammatory markers in cystic fibrosis: a single-centre study |
topic | Gastroenterology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058793/ https://www.ncbi.nlm.nih.gov/pubmed/36053631 http://dx.doi.org/10.1136/bmjpo-2022-001422 |
work_keys_str_mv | AT rodajuliana faecalcalprotectinandrectalhistologicalinflammatorymarkersincysticfibrosisasinglecentrestudy AT maiacarla faecalcalprotectinandrectalhistologicalinflammatorymarkersincysticfibrosisasinglecentrestudy AT almeidasusana faecalcalprotectinandrectalhistologicalinflammatorymarkersincysticfibrosisasinglecentrestudy AT oliveiraruicaetano faecalcalprotectinandrectalhistologicalinflammatorymarkersincysticfibrosisasinglecentrestudy AT ferreiraricardo faecalcalprotectinandrectalhistologicalinflammatorymarkersincysticfibrosisasinglecentrestudy AT oliveiraguiomar faecalcalprotectinandrectalhistologicalinflammatorymarkersincysticfibrosisasinglecentrestudy |